DEBORAH MURPHY: Open Payments
NPI 1205830783 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,531 in 115 payments from 16 companies in 2025. Trend: 2023 $3,285 · 2024 $2,914 · 2025 $2,531
Food & beverage: $2,531
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 28 | $516 |
| Vanda Pharmaceuticals Inc. | 5 | $312 |
| ABBVIE INC. | 15 | $285 |
| Otsuka America Pharmaceutical, Inc. | 11 | $253 |
| Teva Pharmaceuticals USA, Inc. | 7 | $233 |
| Collegium Pharmaceutical, Inc. | 7 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $179 |
| Axsome Therapeutics, Inc. | 7 | $158 |
| Lundbeck LLC | 14 | $156 |
| Almatica Pharma LLC | 3 | $64 |
Products named: INGREZZA, REXULTI, VRAYLAR, FANAPT, AUSTEDO XR, Jornay PM, CAPLYTA, Auvelity.
Industry payments across KS — which companies pay providers there.
